MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Consolidated Edison Inc (NYSE:ED) Q1 2026 Earnings: GAAP Beat Fails to Mask Revenue and Adjusted EPS Miss ↗
Via Chartmill
Tickers ED
Affirm Holdings Inc (NASDAQ:AFRM) Earnings Beat Drives After-Hours Gains ↗
Via Chartmill
Topics Earnings
Tickers AFRM
Exposures Financial
News Corp (NASDAQ:NWSA) Beats Q3 Estimates on Digital Real Estate and Dow Jones Strength ↗
Via Chartmill
Topics Stocks
Tickers ASX:NWS NWS NWSA
Exposures US Equities
Crinetics Pharmaceuticals (NASDAQ:CRNX) Beats Q1 Expectations on Strong PALSONIFY Launch, Stock Slips After Hours ↗
Via Chartmill
Tickers CRNX
CORSAIR GAMING INC (NASDAQ:CRSR) Smashes Q1 Estimates as Profit Surge Outpaces Revenue Dip ↗
Via Chartmill
Tickers CRSR
HubSpot Inc (NYSE:HUBS) Faces 12% Selloff After Q1 Beat and Disappointing Revenue Guidance ↗
Via Chartmill
Tickers HUBS
Mettler-Toledo International (NYSE:MTD) Edges Lower as Q1 Earnings Beat Fails to Offset Cautious Outlook ↗
Via Chartmill
Topics Earnings
Tickers MTD
Exposures Financial
Clean Energy Fuels Corp (NASDAQ:CLNE) Beats Q1 Estimates on RNG Volume, But Outlook Drags Stock Down ↗
Via Chartmill
Tickers CLNE
Guardant Health (NASDAQ:GH) Smashes Q1 Estimates, Raises Full-Year Guidance on Soaring Screening Revenue ↗
Via Chartmill
Tickers GH
Indie Semiconductor (NASDAQ:INDI) Beats Q1 Earnings, Guides Q2 Above Estimates ↗
Via Chartmill
Tickers INDI
10x Genomics (NASDAQ:TXG) Beats Q1 Estimates But Falls as Revenue Shrinks Year-Over-Year ↗
Via Chartmill
Tickers TXG
Expensify (EXFY) Beats Q1 Estimates but Revenue Slides; Market Reaction Subdued ↗
Via Chartmill
Tickers EXFY
Rocket Companies (NYSE:RKT) Surges After-Hours on Q1 2026 Earnings Beat ↗
Via Chartmill
Tickers RKT
Xenon Pharmaceuticals (NASDAQ:XENE) Reports Mixed Q1 Results as Azetukalner Nears FDA Submission ↗
Via Chartmill
Tickers XENE
Exposures Product Safety
PTC Therapeutics Inc (NASDAQ:PTCT) Delivers Q1 Earnings Beat and Raises 2026 Guidance ↗
Via Chartmill
Topics Earnings
Tickers PTCT
Exposures Financial
SkinHealth Systems (NASDAQ:SKIN) Shares Slide 7.7% After Revenue Miss and Lowered Guidance ↗
Via Chartmill
Tickers SKIN
PubMatic (NASDAQ:PUBM) Q1 2026: Revenue Beat and AI Strategy Fuel Optimism Despite Profitability Miss ↗
Via Chartmill
Topics Artificial Intelligence
Tickers PUBM
Exposures Artificial Intelligence
Maravai LifeSciences (NASDAQ:MRVI) Surges After Crushing Q1 Estimates and Raising Full-Year Guidance ↗
Via Chartmill
Tickers MRVI
Coinbase Global Inc (NASDAQ:COIN) Misses Q1 Estimates, Shares Dip 4.5% as Revenue Falls Short. ↗
Via Chartmill
Tickers COIN
Turtle Beach Corp (NASDAQ:TBCH) Faces Revenue and Earnings Miss in Q1 2026, Stock Dips After-Hours ↗
Via Chartmill
Topics Earnings
Tickers TBCH
Exposures Financial
Outset Medical (NASDAQ:OM) Falls After Q1 Revenue Miss, Despite Record Gross Margins ↗
Via Chartmill
Tickers OM
Assured Guaranty Ltd (NYSE:AGO) Posts Q1 2026 Earnings Beat Despite Revenue Shortfall ↗
Via Chartmill
Topics Earnings
Tickers AGO
Exposures Financial
Concentra Group Holdings Parent (NYSE:CON) Beats Q1 Estimates and Raises Guidance, Shares Surge ↗
Via Chartmill
Tickers CON
Progyny Inc (NASDAQ:PGNY) Beats Q1 Estimates and Guides Above Consensus as Selling Season Off to a Strong Start ↗
Via Chartmill
Tickers PGNY
TECTONIC THERAPEUTIC INC (NASDAQ:TECX) Q1 Loss Wider Than Expected, Pipeline Progress Provides Key Catalyst ↗
Via Chartmill
Tickers TECX
MercadoLibre Inc (NASDAQ:MELI) Revenue Beat Overshadowed by Fourth Straight Profit Miss ↗
Via Chartmill
Tickers MELI
What's going on in today's after hours session: S&P500 movers ↗
Via Chartmill
Tickers AKAM COIN DRI EXPE GEN GILD
BioLife Solutions Inc (NASDAQ:BLFS) Q1 2026 Earnings Beat Signals Profitability Milestone ↗
Via Chartmill
Topics Earnings
Tickers BLFS
Exposures Financial
Prothena (NASDAQ:PRTA) Smashes Q1 Estimates on $50 Million Milestone Payment, Shares Steady ↗
Via Chartmill
Tickers PRTA
Arcturus Therapeutics Holdings (NASDAQ:ARCT) Q1 2026 Results: Revenue Miss Weighs on Sentiment as Pipeline Advances ↗
Via Chartmill
Tickers ARCT
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story